A European Observational Study to Evaluate the Safety and the Effectiveness of Safinamide in Routine Clinical Practice: The SYNAPSES Trial

Article type: Correction

Authors: Abbruzzese, Giovanni^a | Kulisevsky, Jaime^b | Bergmans, Bruno^c | Gomez-Esteban, Juan C.^d | Kägi, Georg^e | Raw, Jason^f | Stefani, Alessandro^g | Warnecke, Tobias^h | Jost, Wolfgang H.ⁱ | the SYNAPSES Study Investigators Group

Affiliations: [a] DINOGMI, University of Genoa, Genova, Italy | [b] Sant Pau Hospital, Universitat Aut‘onoma de Barcelona, CIBERNED, Barcelona, Spain | [c] Department of Neurology, AZ St-Jan Brugge-Oostende AV, Campus Brugge, Brugge & Ghent University Hospital, Ghent, Belgium | [d] Biocruces Research Institute, Barakaldo, Spain | [e] Department of Neurology, Cantonal Hospital St.Gallen, Switzerland | [f] Fairfield General Hospital, Bury, Greater Manchester, UK | [g] Parkinson Center, University Policlinico Tor Vergata, Roma, Italy | [h] Department of Neurology, University of Muenster, Muenster, Germany | [i] Parkinson-Klinik Ortenau, University of Freiburg, Wolfach, Germany

DOI: 10.3233/JPD-219007

Journal: Journal of Parkinson's Disease, vol. 12, no. 1, pp. 473-473, 2022